Opportunity Information: Apply for RFA MD 22 004
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional), Funding Opportunity Number RFA-MD-22-004, is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant opportunity designed to push practical, commercializable solutions that measurably improve minority health and reduce or eliminate health disparities. The focus is on taking a technology, product, process, or service beyond an idea and into development with a clear path toward real-world use, especially in communities that experience disproportionate disease burden and poorer health outcomes. The opportunity sits within NIH's broader health mission and aligns with multiple activity areas listed in the announcement, including health, education, and food and nutrition, reflecting the reality that disparities are shaped by both clinical and non-clinical factors.
The core purpose of the FOA is to support small businesses that can build innovations that work in the settings where disparities occur. NIH is explicitly looking for solutions that are not only effective from a scientific or technical standpoint, but also affordable and culturally acceptable, which is a key distinction from many purely technology-driven programs. In practice, this means applicants are expected to think through adoption barriers up front: cost constraints, usability, language access, community trust, and fit with cultural practices and local care environments. The targeted outcomes are improvements in health for one or more NIH-defined population groups that experience health disparities, which commonly include racial and ethnic minority groups and other disparity populations recognized by NIH policy and research frameworks.
Mechanism-wise, this is an SBIR R43/R44 opportunity, meaning it supports the typical SBIR phased pathway. Phase I (R43) generally supports early-stage feasibility and proof-of-concept work, while Phase II (R44) supports further development, refinement, and steps needed to move toward commercialization and broader implementation. The announcement notes "Clinical Trial Optional," which indicates that applicants may propose clinical trials if they are appropriate for the stage and nature of the innovation, but a clinical trial is not automatically required. This flexibility is important for small businesses, because some disparity-reduction innovations are best validated through usability, implementation, or effectiveness studies that may or may not meet NIH's definition of a clinical trial, depending on how outcomes and interventions are structured.
Eligibility is limited to United States small business concerns, emphasizing the program's intent to stimulate domestic innovation and commercialization. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. That said, the FOA leaves room for "foreign components" as defined in the NIH Grants Policy Statement, which can sometimes allow certain international elements if they are well-justified and permitted under NIH policy. In other words, the applicant organization must be a U.S. small business, and the project must be structured so that any non-U.S. involvement complies with NIH rules and does not constitute an ineligible non-domestic component.
From an administrative standpoint, this is a discretionary grant under NIH, and the original closing date listed for the opportunity was April 4, 2022, with a creation date of January 5, 2022. The announcement references multiple Assistance Listing (CFDA) numbers (93.233, 93.242, 93.279, 93.286, 93.307, 93.350, 93.837, 93.838, 93.839, 93.840, 93.847, 93.866), which signals that the participating NIH Institutes and Centers may span several biomedical and public health domains, and that projects could fit within a range of NIH portfolios so long as they directly address minority health and health disparities.
Overall, the FOA is best understood as a commercialization-oriented NIH research and development opportunity for U.S. small businesses that can deliver practical innovations tailored to disparity-affected communities. Competitive projects are likely to be those that demonstrate a credible technical plan, a clear commercialization pathway, and a thoughtful strategy for ensuring the solution is accessible, affordable, and acceptable to the populations it is meant to serve, with evaluation plans that can convincingly show impact on disparity-related outcomes.Apply for RFA MD 22 004
- The National Institutes of Health in the education, food and nutrition, health sector is offering a public funding opportunity titled "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233, 93.242, 93.279, 93.286, 93.307, 93.350, 93.837, 93.838, 93.839, 93.840, 93.847, 93.866.
- This funding opportunity was created on 2022-01-05.
- Applicants must submit their applications by 2022-04-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities" funding opportunity?
It is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding opportunity focused on supporting small businesses to develop practical, commercializable innovations that measurably improve minority health and reduce or eliminate health disparities.
What is the Funding Opportunity Number (FOA) for this grant?
The Funding Opportunity Number is RFA-MD-22-004.
Which SBIR mechanisms are supported under this FOA?
This opportunity supports the SBIR phased pathway using R43/R44 mechanisms: Phase I (R43) and Phase II (R44).
What is the main purpose of this FOA?
The core purpose is to help U.S. small businesses move an innovation beyond the idea stage into development, with a clear path toward real-world use and commercialization, specifically in communities experiencing disproportionate disease burden and poorer health outcomes.
What kinds of innovations are appropriate for this program?
The FOA supports innovations such as a technology, product, process, or service, as long as it is designed to measurably improve minority health and reduce or eliminate health disparities and can plausibly move toward real-world implementation and commercialization.
Is this FOA only for medical or clinical technologies?
No. While it sits within NIH's broader health mission, the announcement aligns with multiple activity areas (including health, education, and food and nutrition), reflecting that health disparities are shaped by both clinical and non-clinical factors.
What makes this FOA different from purely technology-driven R&D programs?
NIH is explicitly looking for solutions that are not only scientifically or technically effective, but also affordable and culturally acceptable. Applicants are expected to think through adoption barriers such as cost constraints, usability, language access, community trust, cultural practices, and fit with local care environments.
Who is eligible to apply?
Eligibility is limited to United States small business concerns under the SBIR program. The FOA emphasizes domestic innovation and commercialization.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply under this opportunity.
Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations are not eligible under this FOA.
Can a project include any international involvement at all?
The FOA notes that "foreign components" may be possible as defined in the NIH Grants Policy Statement, if well-justified and allowed under NIH policy. However, the applicant organization must be a U.S. small business, and any non-U.S. involvement must comply with NIH rules and not become an ineligible non-domestic component.
What does "Clinical Trial Optional" mean in this FOA?
"Clinical Trial Optional" means applicants may propose a clinical trial if it fits the innovation and its stage of development, but a clinical trial is not required by default.
Is a clinical trial required to be competitive?
The FOA does not state that a clinical trial is required. It highlights flexibility because some innovations aimed at reducing disparities may be best evaluated through usability, implementation, or effectiveness studies that may or may not meet NIH's definition of a clinical trial.
What is Phase I (R43) intended to support?
Phase I (R43) generally supports early-stage work such as feasibility testing and proof-of-concept to show that the innovation can work and merits further development.
What is Phase II (R44) intended to support?
Phase II (R44) generally supports further development and refinement, along with steps needed to move toward commercialization and broader implementation.
What outcomes is NIH targeting with this FOA?
The FOA targets measurable improvements in health for one or more NIH-defined population groups that experience health disparities, including racial and ethnic minority groups and other disparity populations recognized by NIH policy and research frameworks.
Where should innovations be designed to work?
NIH is looking for innovations that work in the real-world settings where disparities occur, meaning the solution should fit the environments, workflows, and constraints present in disparity-affected communities.
What kinds of adoption barriers should applicants address?
The FOA points to barriers such as cost constraints, usability, language access, community trust, and alignment with cultural practices and local care environments.
What type of grant is this from an administrative standpoint?
It is a discretionary grant under NIH.
When was this funding opportunity created and when was the original closing date?
The creation date listed is January 5, 2022, and the original closing date listed is April 4, 2022.
What Assistance Listing (CFDA) numbers are associated with this FOA?
The announcement references multiple Assistance Listing numbers: 93.233, 93.242, 93.279, 93.286, 93.307, 93.350, 93.837, 93.838, 93.839, 93.840, 93.847, 93.866.
What do the multiple Assistance Listing (CFDA) numbers imply?
They suggest that participating NIH Institutes and Centers may span multiple biomedical and public health domains. Projects may align with a range of NIH portfolios as long as they directly address minority health and health disparities.
How commercialization-oriented is this opportunity?
It is strongly commercialization-oriented. The FOA is designed to push practical solutions with a clear pathway toward real-world use, and competitive projects are expected to show a credible technical plan and a clear commercialization pathway.
What is NIH likely to expect in a strong evaluation plan?
Based on the FOA description, strong projects are likely to include evaluation plans that can convincingly demonstrate impact on disparity-related outcomes and show that the innovation is accessible, affordable, and acceptable to the intended populations.
Does the FOA emphasize community fit and cultural acceptability?
Yes. A key theme is that solutions should be culturally acceptable and designed for the communities they aim to serve, with attention to factors like language access and community trust.
In one sentence, who is this FOA best suited for?
This FOA is best suited for U.S. small businesses developing commercializable innovations that can be implemented in real-world settings to measurably improve minority health and reduce or eliminate health disparities.
Browse more opportunities from the same category: Education, Food and Nutrition, Health
Next opportunity: Indian Business Incubators Program (IBIP) Grants under the Native American Business Incubator Act of 2020
Previous opportunity: HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MD 22 004
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MD 22 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Education Program on Translational Devices (R25 Clinical Trial Not Allowed) Apply for PAR 22 146 Funding Number: PAR 22 146 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $250,000 |
| Interventions that Address Structural Racism to Reduce Kidney Health Disparities - (U01 - Clinical Trial Required) Apply for RFA DK 22 014 Funding Number: RFA DK 22 014 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $500,000 |
| Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed) Apply for RFA DK 22 015 Funding Number: RFA DK 22 015 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $500,000 |
| Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed) Apply for RFA DK 23 003 Funding Number: RFA DK 23 003 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Centers for AIDS Research (P30 Clinical Trial Not Allowed) Apply for PAR 23 116 Funding Number: PAR 23 116 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) Apply for PAR 23 117 Funding Number: PAR 23 117 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) Apply for PAR 23 191 Funding Number: PAR 23 191 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $275,000 |
| Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) Apply for PAR 23 190 Funding Number: PAR 23 190 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $400,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Apply for PAR 24 091 Funding Number: PAR 24 091 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Apply for PAR 24 092 Funding Number: PAR 24 092 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) Apply for RFA MD 24 006 Funding Number: RFA MD 24 006 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (R01 Clinical Trial Optional) Apply for PA 25 249 Funding Number: PA 25 249 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Apply for PAR 25 354 Funding Number: PAR 25 354 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Apply for PAR 25 355 Funding Number: PAR 25 355 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: Case Dependent |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) Apply for RFA OD 25 003 Funding Number: RFA OD 25 003 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MD 22 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.